Suppr超能文献

男性无症状性性接触者中氟喹诺酮耐药标志物和双重耐药标志物的流行情况。

Prevalence of fluoroquinolone-resistance markers, and dual-class-resistance markers, in asymptomatic men who have sex with men.

机构信息

Molecular Microbiology Research Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.

Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Victoria, Australia.

出版信息

J Med Microbiol. 2021 Sep;70(9). doi: 10.1099/jmm.0.001429.

Abstract

Failure of fluoroquinolones, the principal treatment option for macrolide-resistant infections, has recently emerged. This is of particular concern for men who have sex with men (MSM), who have high proportions of macrolide-resistant infections. Treatment failure with moxifloxacin is likely the result of single nucleotide polymorphisms (SNPs) in , whilst concurrent mutations may play a role. The levels of fluoroquinolone resistance and dual-class (i.e. macrolide and fluoroquinolone) resistance in among asymptomatic MSM is unknown. To (i) determine the proportion of fluoroquinolone resistance and dual-class resistance in infections among asymptomatic MSM, (ii) explore any clinical and behavioural associations with fluoroquinolone resistance, and (iii) determine the distribution of antibiotic resistance among sequence types (STs). positive samples (=94) were obtained from 1001 asymptomatic MSM enrolled in a study at Melbourne Sexual Health Centre (Carlton, Australia) between August 2016 and September 2017. Sanger sequencing was performed to determine the proportion of infections with SNPs in that have previously been associated with failure of moxifloxacin (corresponding to amino changes S83I, D83R, D87Y and D87N) and in (corresponding to amino acid changes M95I, D99N, D99Y and D99G). Associations between clinical/behavioural factors and SNPs were examined. Strain typing was performed by sequencing a portion of the gene. The proportion of MSM with infections harbouring and SNPs was 13.0 % [95 % confidence interval (CI): 6.8-23.2 %] and 4.7 % (95 % CI: 1.1-13.4 %), respectively; dual-class resistance was 13.0 %. No significant clinical/behavioural associations were found. Antibiotic resistance was not restricted to specific STs. One in eight (13 %) of asymptomatic MSM with had an infection with dual-class-resistance mutations. Typing by sequence suggested fluoroquinolone resistance is arising from independent mutation events. This study illustrates that asymptomatic MSM may act as a reservoir for antibiotic-resistant .

摘要

氟喹诺酮类药物是治疗大环内酯类耐药感染的主要选择,但最近该药物已失效。这对男男性行为者(MSM)来说尤其令人担忧,因为他们的大环内酯类耐药感染比例较高。莫西沙星治疗失败可能是由于 中的单核苷酸多态性(SNP)所致,而同时存在的 突变可能也发挥了作用。在无症状 MSM 中, 中的氟喹诺酮类药物耐药和双药耐药(即大环内酯类和氟喹诺酮类)的水平尚不清楚。本研究旨在:(i)确定无症状 MSM 中 感染的氟喹诺酮类耐药和双药耐药的比例;(ii)探索与氟喹诺酮类耐药相关的任何临床和行为因素;(iii)确定 序列型(ST)中抗生素耐药的分布情况。本研究于 2016 年 8 月至 2017 年 9 月在澳大利亚卡尔顿的墨尔本性健康中心(Melbourne Sexual Health Centre)招募了 1001 名无症状 MSM ,从中获取了 94 份 阳性样本。采用 Sanger 测序来确定先前与莫西沙星治疗失败相关的 中存在的与 SNPs(对应于氨基酸变化 S83I、D83R、D87Y 和 D87N)和 中存在的 SNPs(对应于氨基酸变化 M95I、D99N、D99Y 和 D99G)的 感染比例。检测了临床/行为因素与 SNPs 之间的相关性。通过测序 基因的一部分来进行菌株分型。携带 和 SNPs 的 MSM 感染比例分别为 13.0%(95%可信区间:6.8-23.2%)和 4.7%(95%可信区间:1.1-13.4%),双药耐药比例为 13.0%。未发现有统计学意义的临床/行为相关性。抗生素耐药性不限于特定的 ST。八分之一(13%)的无症状 MSM 携带 感染,该感染存在双药耐药突变。基于 序列的分型表明,氟喹诺酮类耐药性是由独立的突变事件引起的。本研究表明,无症状 MSM 可能是抗生素耐药性 的储主。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/216b/8697509/9faeb0cab053/jmm-70-1429-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验